MOL NEUROBIOL
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 神经科学 Neurosciences | SCIE | Q1 | 59/330 |
82.1%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 神经科学 Neurosciences | SCIE | Q1 | 50/268 JCI 1.29 |
81.7%
|
Molecular Neurobiology is a leading peer-reviewed journal dedicated to advancing the understanding of the molecular mechanisms underlying nervous system function and dysfunction. Published by Springer Nature, the journal serves as a premier platform for high-impact research that bridges molecular biology, neuroscience, and clinical neurology. Its scope encompasses a broad spectrum of topics, including neuronal development, synaptic plasticity, neurodegeneration, neuroinflammation, neurogenetics, and molecular aspects of psychiatric disorders. The journal primarily publishes original research articles, comprehensive reviews, and short communications, with a strong emphasis on studies that elucidate the genetic, epigenetic, and signaling pathways driving neural processes. The target audience includes molecular biologists, neuroscientists, neuropharmacologists, clinical neurologists, and biomedical researchers seeking cutting-edge insights into the molecular basis of neurological diseases. Notable features include its rigorous single-blind peer review process and its availability in both subscription and open access models, allowing authors to opt for immediate public access. With a 2026 Impact Factor of 5.5000, Molecular Neurobiology is consistently ranked in the JCR Q1 quartile, reflecting its high citation impact and prestige within the neuroscience and molecular biology categories. This standing underscores the journal’s role as a vital resource for disseminating foundational discoveries that drive translational research and therapeutic innovation in neurobiology.